Israel Englander Ab Cellera Biologics Inc. Call Options Transaction History

Millennium Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $1.02 Million - $1.56 Million	139,100 Added 86.45%	300,000 $2.26 Million
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $1.32 Million - $2.02 Million	-139,100 Reduced 46.37%	160,900 $1.63 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $2.76 Million - $4.1 Million	300,000 New	300,000 $2.97 Million

165

119M

239K

200K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $739M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.